Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
glycyphagus domesticus allergen extract
- Development stage
- Preclinical
- Lead developer
- Citeq Biologics
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intradermal, Subcutaneous, Sublingual
01
Overview
Glycyphagus domesticus allergen extract is an immunomodulatory agent developed by LETI Pharma. [15, 16] It is a biological product derived from the storage mite *Glycyphagus domesticus* and is intended for both diagnosis and treatment of allergies to this specific mite. [11, 14, 16] As a therapeutic, it is used in allergen-specific immunotherapy (AIT), a process that involves administering gradually increasing doses of the allergen to desensitize the immune system. [14] This aims to induce long-term tolerance and reduce allergic symptoms upon natural exposure. The provided clinical trial information indicates that it is being evaluated to determine its biological activity and establish a safe and effective therapeutic dosage.
- Other names
- House mite allergen extract
02
Targets
IgE (Immunoglobulin E)
Beyond the preview
Go deeper on glycyphagus domesticus allergen extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on glycyphagus domesticus allergen extract.